|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net income | |||||
| Depreciation and amortization | |||||
| Asset impairments | |||||
| Gain on previously held equity investment in Thinx | |||||
| Stock-based compensation | |||||
| Deferred income taxes | |||||
| Net (gains) losses on asset and business dispositions | |||||
| Equity companies' earnings (in excess of) less than dividends paid | |||||
| Operating working capital | |||||
| Postretirement benefits | |||||
| Other | |||||
| Cash Provided by Operations | |||||
| Investing Activities | |||||
| Capital spending | |||||
| Acquisition of business, net of cash acquired | |||||
| Proceeds from asset and business dispositions | |||||
| Investments in time deposits | |||||
| Maturities of time deposits | |||||
| Other | |||||
| Cash Used for Investing | |||||
| Financing Activities | |||||
| Cash dividends paid | |||||
| Change in short-term debt | |||||
| Debt proceeds | |||||
| Debt repayments | |||||
| Proceeds from exercise of stock options | |||||
| Repurchases of common stock | |||||
| Cash paid for redemption of common securities of Thinx | |||||
| Cash dividends paid to noncontrolling interests | |||||
| Other | |||||
| Cash Used for Financing | |||||
| Effect of Exchange Rate Changes on Cash and Cash Equivalents | |||||
| Change in Cash and Cash Equivalents | |||||
| Cash and cash equivalents from continuing operations - beginning of period | |||||
| Cash and cash equivalents from discontinued operations - beginning of period(a) | |||||
| Cash and Cash Equivalents - Beginning of Year | |||||
| Cash and cash equivalents from continuing operations - end of period | |||||
| Cash and cash equivalents from discontinued operations - end of period(a) | |||||
| Cash and Cash Equivalents - End of Year |
Loading...